相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mathematical Modeling of In Vivo Alpha Particle Generators and Chelator Stability
Nouran R. R. Zaid et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2023)
Targeted a-Emitter Therapy with 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial
Ebrahim S. Delpassand et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Dosimetry of [212Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free 208Tl on Tissue Absorbed Doses
Kelly D. Orcutt et al.
MOLECULES (2022)
Predictive factors of tumor sink effect: Insights from 177Lu-Prostate-specific membrane antigen therapy
Murat Tuncel et al.
ANNALS OF NUCLEAR MEDICINE (2021)
A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice
Nouran R. R. Zaid et al.
PHARMACEUTICS (2021)
Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma
Mengshi Li et al.
CANCERS (2021)
Clinically Applicable Cyclotron-Produced Gallium-68 Gives High-Yield Radiolabeling of DOTA-Based Tracers
Emma Jussing et al.
BIOMOLECULES (2021)
Getting a lead on Pb2+-amide chelators for 203/212Pb radiopharmaceuticals
Aidan Ingham et al.
DALTON TRANSACTIONS (2021)
Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward
Danny Feijtel et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Molecular Bismuth Cations: Assessment of Soft Lewis Acidity
Jacqueline Ramler et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003
Astri Fjelde Maaland et al.
PLOS ONE (2020)
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer
Mengshi Li et al.
CURRENT MEDICINAL CHEMISTRY (2020)
An octadentate bis(semicarbazone) macrocycle: a potential chelator for lead and bismuth radiopharmaceuticals
Jaclyn L. Lange et al.
DALTON TRANSACTIONS (2020)
Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model
Tania A. Rozgaja Stallons et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma Targeting
Jianquan Yang et al.
MOLECULAR PHARMACEUTICS (2019)
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing the lead into PSMA-targeted alpha therapy?
Jose Carlos dos Santos et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy
Dongyoul Lee et al.
RADIATION RESEARCH (2018)
Relevant tumor sink effect in prostate cancer patients receiving 177Lu-PSMA-617 radioligand therapy
Christian Filss et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2018)
Biodistribution, Pharmacokinetics, and Dosimetry of 177Lu-, 90Y-, and 111In-Labeled Somatostatin Receptor Antagonist OPS201 in Comparison to the Agonist 177Lu-DOTATATE: The Mass Effect
Guillaume P. Nicolas et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Automated cassette-based production of high specific activity [203/212pb] peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer
Mengshi Li et al.
APPLIED RADIATION AND ISOTOPES (2017)
Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
Dik J. Kwekkeboom et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2016)
225Ac-PSMA-617 for PSMA-Targeted a-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Spectroscopic, structural, and thermodynamic aspects of the stereochemically active lone pair on lead(II): Structure of the lead(II) dota complex
Joseph W. Nugent et al.
POLYHEDRON (2015)
Molecular Pathways: Targeted α-Particle Radiation Therapy
Kwamena E. Baidoo et al.
CLINICAL CANCER RESEARCH (2013)
Search of ligands suitable for 212Pb/212Bi in vivo generators
Barbara Bartos et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2013)
Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: Radiolabeling, serum stability, and biodistribution and tumor uptake studies
Chi Soo Kang et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells
Balrik Kailey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
212Pb/212Bi GENERATOR FOR NUCLEAR MEDICINE
P. P. Boldyrev et al.
ATOMIC ENERGY (2012)
Simplified NaCl Based 68Ga Concentration and Labeling Procedure for Rapid Synthesis of 68Ga Radiopharmaceuticals in High Radiochemical Purity
Dirk Mueller et al.
BIOCONJUGATE CHEMISTRY (2012)
Comparison of receptor affinity of Sc-nat-DOTA-TATE versus Ga-nat-DOTA-TATE
Eftychia Koumarianou et al.
NUCLEAR MEDICINE REVIEW (2011)
MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy
George Sgouros et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Alpha-particles for targeted therapy
George Sgouros
ADVANCED DRUG DELIVERY REVIEWS (2008)
New insights into the complexation of lead(II) by 1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane (DOTAM): Structural, thermodynamic, and kinetic studies
Francois Cuenot et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2008)
203Pb-labeled α-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection
Yubin Miao et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator
FM Su et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Melanoma therapy via peptide-targeted α-radiation
YB Miao et al.
CLINICAL CANCER RESEARCH (2005)
Phage display-derived peptides as a therapeutic alternatives to antibodies
RC Ladner et al.
DRUG DISCOVERY TODAY (2004)
Potential in vivo generator for alpha-particle therapy with Bi-212: Presentation of a system to minimize escape of daughter nuclide after decay of Pb-212 to Bi-212
G Henriksen et al.
RADIOCHIMICA ACTA (2003)
分享论文
